Return
B cell depletion in autoimmune disease: in vivo CAR-T or T cell engagers?
M
R
DOI:10.1038/s41587-026-03069-5.png)
Abstract
En 中文
Deep B cell depletion is delivering transformative clinical results in autoimmune diseases. Dealmakers are wagering on the best tools for the job.
Keywords:
Life Sciences
general
Biotechnology
Biomedicine
Agriculture
Biomedical Engineering/Biotechnology
Bioinformatics
Journal
IF:
41.7
Papers:
1.2W
Citations:
10.1W
